GLYCOPYRROLATE MSDS PDF

SAFETY DATA SHEET. PRODUCT: Glycopyrrolate Injection USP. Section 1: PRODUCT AND COMPANY INFORMATION. 54/1, Boodhihal village,. Nelamangala. Glycopyrrolate. 1-Methylpyrrolidyl alpha-phenylcyclopentaneglycolate methobromide;. Glycopyrrolate bromide; Glycopyrronium bromide. Glycopyrronium (as the bromide salt glycopyrrolate) is a synthetic anticholinergic agent In October , glycopyrrolate was approved by the FDA for use as a FDA label. Download ( KB). MSDS. Download ( KB).

Author: Zolorg Fenriran
Country: Slovenia
Language: English (Spanish)
Genre: Photos
Published (Last): 5 October 2007
Pages: 70
PDF File Size: 5.49 Mb
ePub File Size: 10.21 Mb
ISBN: 381-9-39353-417-5
Downloads: 70667
Price: Free* [*Free Regsitration Required]
Uploader: Takazahn

The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Ajulemic acid. Bezitramide The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Bezitramide.

Loratadine Glycopyrronium may increase the anticholinergic activities of Loratadine. The risk or severity of adverse effects can be increased when Glycopyrronium mdss combined with Opium. Benactyzine The risk or severity of adverse effects can be increased when Benactyzine is combined with Glycopyrronium. Dibekacin The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Dibekacin. Capsaicin The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Capsaicin.

Dihydrocodeine The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Dihydrocodeine.

Glycopyrronium

Ractopamine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Ractopamine. Isoetarine The risk or severity of Tachycardia can be increased when Isoetarine is combined with Glycopyrronium.

Poldine The risk or severity of adverse effects can be increased when Poldine is combined with Glycopyrronium. Gantacurium Chloride Glycopyrronium may increase the anticholinergic activities of Gantacurium Chloride. Coumaphos The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Coumaphos.

  EL ULTIMO GRUMETE DE LA BAQUEDANO LIBRO PDF

The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Hexafluronium. The risk or severity of adverse effects can be increased when Etybenzatropine is combined with Glycopyrronium.

The therapeutic efficacy of Plantago seed can be decreased when used in combination with Glycopyrronium. The therapeutic efficacy of Linaclotide can be decreased when used in combination with Glycopyrronium. The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Phenoperidine.

The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Netilmicin. The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with CP Chlorprothixene The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Glycopyrronium.

Pricing information is supplied for informational purposes only. Homatropine Methylbromide The risk or severity of adverse effects can be increased when Homatropine Methylbromide is combined with Glycopyrronium.

The risk or severity of adverse effects can be increased when Cycrimine is combined with Glycopyrronium. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with 4-Methoxyamphetamine. Dexmedetomidine The risk or severity of Tachycardia can be increased when Dexmedetomidine is combined with Glycopyrronium.

The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Ibipinabant. The risk or severity of adverse effects can be increased when Metocurine is combined with Glycopyrronium.

  LIVRO PROJETO DE ALGORITMOS NIVIO ZIVIANI PDF

The risk or severity of adverse effects can be increased when Maprotiline is combined with Glycopyrronium.

Butalbital Butalbital may increase the anticholinergic activities of Glycopyrronium. The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Donepezil. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Ephedra.

Aripiprazole The risk or severity of adverse effects can be increased when Aripiprazole is combined with Glycopyrronium. The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Diphenoxylate.

Glycopyrronium – DrugBank

The risk or severity of Tachycardia can be increased when Dexmedetomidine is combined with Glycopyrronium. The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Palmidrol.

Bethanidine The risk or severity of Tachycardia can be increased when Bethanidine is combined with Glycopyrronium.

The risk or severity of Tachycardia can be increased when Labetalol is combined with Glycopyrronium. The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Butorphanol. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Chlorphentermine. The therapeutic efficacy of Glycopyrronium glycopyrrolatee be decreased when used in combination with Cinchocaine.

VPN